← Leaderboards

Timothy S Kern

Case Western Reserve University

Google Scholar ↗PubMed ↗ORCID ↗

$20,435,317

Attributed

$20,646,286

Total exposure

13

Grants

10

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2005–23

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$22,815,366 · 12

VA$0 · 2

By mechanism

R01$9,525,962 · 3

R24$8,113,408 · 1

P01$2,452,964 · 2

P30$1,947,844 · 4

R21$421,938 · 1

R56$353,250 · 1

Top collaborators

Masaru Miyagi2 shared

Most similar at Case Western Reserve University

Same institution · by research overlap

Yuanyuan Chen$2,842,773
Kelly S Gibson$845,348
Igor R Efimov$20,527,065
Kevin L Kilgore$17,814,943
Brian Smith$4,207,113

Others in their field

Top investigators on “Diabetic Retinopathy”

John M Lachin · George Washington University$140,240,809
David M Nathan · Massachusetts Institute Of Technology$123,291,647
Rose A Gubitosi-Klug · Case Western Reserve University$71,942,336
Rohit Varma · University Of Southern California$56,244,772
Keri Hammel · The Emmes Company, Llc$53,700,408
Adam R Glassman · Jaeb Center For Health Research, Inc.$50,075,374

Research focus

Diabetic RetinopathyAnimalsDiabetes MellitusRetinaVisionRetinal DiseasesRetinalBlood VesselsLesionInflammatoryAdultBlindnessPlayCellsPathogenesisBlood CapillariesInflammationOxidative StressResearch PersonnelDiabeticHyperglycemiaLeukocytesPathologyMolecular

Grant awards (66)

Neutrophil elastase and Gasdermin D in diabetic retinopathy$392,500

R01 · FY2023 · EY · contact PI

Neutrophil elastase and Gasdermin D in diabetic retinopathy$380,725

R01 · FY2022 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$467,301

R01 · FY2021 · EY · contact PI

Neutrophil elastase and Gasdermin D in diabetic retinopathy$392,500

R01 · FY2021 · EY · contact PI

Specialized Animal Resources Core$120,644

P30 · FY2021 · EY · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2021 · VA · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$365,327

R01 · FY2020 · EY · contact PI

Specialized Animal Resources Core$120,644

P30 · FY2020 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$116,337

R01 · FY2020 · EY · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2020 · VA · contact PI

Novel therapies to inhibit Diabetic Retinopathy$1,599,715

R24 · FY2019 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$379,086

R01 · FY2019 · EY · contact PI

Specialized Animal Resources Core$120,019

P30 · FY2019 · EY · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2019 · VA · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2019 · VA · contact PI

Novel therapies to inhibit diabetic retinopathy$1,611,990

R24 · FY2018 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$402,102

R01 · FY2018 · EY · contact PI

Specialized Animal Resources Core$119,894

P30 · FY2018 · EY · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2018 · VA · contact PI

Novel therapies to inhibit diabetic retinopathy$1,616,335

R24 · FY2017 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$402,102

R01 · FY2017 · EY · contact PI

Specialized Animal Resources Core$119,894

P30 · FY2017 · EY · contact PI

Acetylation and diabetic retinopathy$0

I01 · FY2017 · VA · contact PI

BLR&D Research Career Scientist Application$0

IK6 · FY2017 · VA · contact PI

Novel therapies to inhibit diabetic retinopathy$1,617,650

R24 · FY2016 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$396,250

R01 · FY2016 · EY · contact PI

Specialized Animal Resource$181,361

P30 · FY2016 · EY · contact PI

Acetylation and diabetic retinopathy$0

I01 · FY2016 · VA · contact PI

Novel therapies to inhibit diabetic retinopathy$1,667,718

R24 · FY2015 · EY · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$388,325

R01 · FY2015 · EY · contact PI

Specialized Animal Resource$181,361

P30 · FY2015 · EY · contact PI

Acetylation and diabetic retinopathy$0

I01 · FY2015 · VA · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$388,325

R01 · FY2014 · EY · contact PI

Specialized Animal Resource$181,362

P30 · FY2014 · EY · contact PI

Acetylation and diabetic retinopathy$0

I01 · FY2014 · VA · contact PI

Role of Photoreceptors in the Pathogenesis of Diabetic Retinopathy$396,250

R01 · FY2013 · EY · contact PI

Study of diabetic retinopathy$388,409

R01 · FY2013 · EY · contact PI

Global Characterization of Lysine Acetylation in Diabetic Retina$186,438

R21 · FY2013 · EY

Specialized Animal Resource$181,362

P30 · FY2013 · EY · contact PI

Study of diabetic retinopathy$408,852

R01 · FY2012 · EY · contact PI

Global Characterization of Lysine Acetylation in Diabetic Retina$235,500

R21 · FY2012 · EY

Specialized Animal Resource$181,362

P30 · FY2012 · EY · contact PI

Study of diabetic retinopathy$408,852

R01 · FY2011 · EY · contact PI

SPECIALIZED ANIMAL RESOURCE MODULE$101,299

P30 · FY2011 · EY · contact PI

Study of diabetic retinopathy$419,675

R01 · FY2010 · EY · contact PI

SPECIALIZED ANIMAL RESOURCE MODULE$86,260

P30 · FY2010 · EY · contact PI

Study of diabetic retinopathy$353,250

R56 · FY2009 · EY · contact PI

SPECIALIZED ANIMAL RESOURCE MODULE$97,012

P30 · FY2009 · EY · contact PI

Study of diabetic retinopathy$367,560

R01 · FY2008 · EY · contact PI

SPECIALIZED ANIMAL RESOURCE MODULE$81,313

P30 · FY2008 · EY · contact PI

Study of diabetic retinopathy$375,061

R01 · FY2007 · EY · contact PI

SPECIALIZED ANIMAL RESOURCE MODULE$74,057

P30 · FY2007 · EY · contact PI

Study of diabetic retinopathy$377,173

R01 · FY2006 · EY · contact PI

Study of diabetic retinopathy$386,250

R01 · FY2005 · EY

STUDY OF DIABETIC RETINOPATHY$382,500

R01 · FY2004 · EY

STUDY OF DIABETIC RETINOPATHY$382,500

R01 · FY2003 · EY

PATHOGENESIS OF DIABETIC MICROVASCULAR COMPLICATIONS$118,450

P01 · FY2003 · DK

PATHOGENESIS OF DIABETIC MICROVASCULAR COMPLICATIONS$710,475

P01 · FY2002 · DK

STUDY OF DIABETIC RETINOPATHY$382,500

R01 · FY2002 · EY

Oxidative stress &development of diabetic retinopathy$94,628

P01 · FY2002 · DK

CORE--DIGITAL IMAGING$0

P30 · FY2002 · EY

PATHOGENESIS OF DIABETIC MICROVASCULAR COMPLICATIONS$677,762

P01 · FY2001 · DK

STUDY OF DIABETIC RETINOPATHY$379,500

R01 · FY2001 · EY

Oxidative stress &development of diabetic retinopathy$94,628

P01 · FY2001 · DK

PATHOGENESIS OF DIABETIC MICROVASCULAR COMPLICATIONS$662,393

P01 · FY2000 · DK

Oxidative stress &development of diabetic retinopathy$94,628

P01 · FY2000 · DK